Loading clinical trials...
Loading clinical trials...
The goal of this observational study is to better characterise lower-grade gliomas from a molecular and metabolic point of view, so to identify further subgroups of these tumours with different behaviour and, possibly, different treatment susceptibility. Participants of prospective metabolic cohort will be subjected to routine treatment, part of the exceeding tutor material will be subjected to advanced molecular-metabolic analyses to desume their metabolic profile to be then correlated with clinical outcome (progression-free survival, overall survival, response to therapy/progression) and diagnosis (astrocytoma/oligodendroglioma and grade). Critical enzymes identified from metabolic analyses on the first cohort will be tested on a protein level on a retrospective cohort of patients previously operated and for whom fully available clinical history and pathological material is available in Institutional archive (no need for further intervention on these patients) to see if they actually correlate with clinical outcome.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Ospedale San Paolo Bari
Bari, Apulia, Italy
Policlinico Bari University Hospital (Bari, Italy)
Bari, Apulia, Italy
Università Vita-Salute San Raffaele
Milan, Lombardy, Italy
IRCCS Galeazzi-Sant'Ambrogio
Milan, Lombardy, Italy
Start Date
November 14, 2024
Primary Completion Date
August 1, 2026
Completion Date
August 1, 2026
Last Updated
January 27, 2025
110
ESTIMATED participants
Direzione Scientifica IRCCS Galeazzi-Sant'Ambrogio, Milano
CONTACT
+390283502228direzionescientifica.ogsa@grupposandonato.itLead Sponsor
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions